Dietmar Lohmann

Prof. Dr. Dietmar Lohmann is a faculty member at the Institute of Human Genetics, Faculty of Medicine, University of Duisburg-Essen, and is affiliated with the University Hospital Essen. He leads the research group on Ophthalmic Oncology and Genetics within the ZMB's Molecular and Chemical Cell Biology program. His work bridges clinical genetics and molecular oncology, focusing on hereditary eye cancers.

Research Interests: His primary research areas include the genetic basis of retinoblastoma and uveal melanoma, identifying heritable and somatic genetic alterations, tumor predisposition syndromes, and the development of prognostic and predictive biomarkers. His work integrates genomics, molecular pathology, and clinical observation to improve diagnosis and patient outcomes.

Publication Trends: Over the past 15 years, his research has evolved from clinical case studies to large-scale genomic and epigenomic analyses. His recent work emphasizes molecular classification of tumors, liquid biopsies, organoid modeling, and the use of DNA methylation profiling. His publications appear in top-tier journals such as Nature, Nature Genetics, and The Lancet Oncology, reflecting high impact in oncology and genetics.

Scientific Awards:

• No awards mentioned in the provided text.

Advising and Grants: While specific students or grants are not listed, his extensive publication record with consistent co-authors (e.g., Petra Temming, Deniz Kanber, Eva Biewald) suggests active mentorship and team leadership. His involvement in multi-center studies and high-impact collaborations indicates successful grant funding, particularly through German and EU research programs.

Labs and Teams: He leads the Ophthalmic Oncology and Genetics group at the Institute of Human Genetics, part of the ZMB research center. His team conducts research on genetic mechanisms in eye cancers, utilizing next-generation sequencing, organoid models, and clinical data analysis.